Aging is driven by declining NAD+ levels—a molecule critical for cellular energy and repair. UthPeak®’s groundbreaking clinical trial on NMNH (reduced NMN) reveals a 3x NAD+ boost, 5-year biological age reduction, and 35% energy gains, backed by the world’s largest human study. Discover how science is redefining longevity.
UthPeak®’s Clinical Breakthrough: The World’s Largest NMNH (reduced NMN) Trial
UthPeak® has set a new benchmark in longevity science with the world’s first, largest, and longest human clinical trial on NMNH (reduced NMN). This 90-day, double-blind, placebo-controlled study involved 80 healthy participants, rigorously assessing safety, efficacy, and overall well-being. Following the success of clinical-proven Uthever® NMN, UthPeak® reaffirms its commitment to clinically proven anti-aging innovations.
Rigorous Science, Trusted Results
Study Design: Randomized, placebo-controlled, and multi-arm to eliminate bias.
Focus Areas: Safety, NAD+ levels, biological age reversal, energy, and emotional well-being.
Self-GRAS Confirmation: An independent expert panel confirmed NMNH (Reduced NMN)’s safety for commercial use under FDA safety standards.
Key Findings: Safety, Rejuvenation, and Energy
Safety Confirmed
No Adverse Effects: The 90-day trial showed no impact on clinical laboratory tests, including blood chemistry, lipid profile, liver function, renal function and urinalysis.
Industry Benchmark: UthPeak® NMNH’s (Reduced NMN) Self-GRAS (Generally Recognized As Safe) certification underscores its safety and quality, meeting federal regulations for reasonable certainty of no harm.
Turn Back the Clock: 5 Years Younger
Biological age, measured by blood biomarkers, decreased by up to 5 years in the NMNH (Reduced NMN) group. The placebo group’s biological age increased during the trial.
l Biological age reflects aging at the cellular level and is a stronger predictor of longevity than chronological age.
3x NAD+ Boost & 35% Energy Surge
NAD+ Levels: Plasma NAD+ tripled in the NMNH (Reduced NMN) group, while placebo levels remained stagnant.
Energy & Vitality: Participants reported a 35% increase in energy and a 31% improvement in emotional well-being, with fatigue scores dropping significantly.
Why UthPeak® NMNH (Reduced NMN) Stands Apart
Patented Crystalline NMNH (Reduced NMN): The Gold Standard
First Market-Ready NMNH: UthPeak® NMNH (Reduced NMN) offers >98% purity, and compatibility with powders, tablets, capsules, and more dosage forms.
Easier Storage: UthPeak® NMNH (Reduced NMN) offers superior stability with storage at a convenient 2-8°C, ensuring optimal freshness and efficacy, compared to regular NMNH (Reduced NMN) , which requires colder temperatures at -20°C.
Self-GRAS: UthPeak® has become the first NMNH brand to secure self-affirmed GRAS status, achieving this milestone for its application in selected conventional foods, dietary supplements, and medical foods.
Patent Status: Patent pending crystalline form of NMNH.
From Lab to Life: Real-World Benefits
Boost In Energy: Enhanced endurance and reduced fatigue, ideal for high-performance lifestyles.
Cellular Health: Elevated NAD+ supports DNA repair, sirtuin activation, and mitochondrial function—key to slowing age-related decline.
Built for Brands: Safety Meets Scalability
UthPeak® NMNH (Reduced NMN) is a turnkey solution for brands targeting the premium anti-aging market. With clinical validation, Self-GRAS status, and patented technology, it empowers B2B partners to lead in the $30 billion longevity industry.
The Future of Longevity: What’s Next for UthPeak®
EffePharm, creator of the world’s first clinically proven NMN brand, licenses the “Uth” series (Uthever® NMN and UthPeak® NMNH ) to 40+ global brands.
UthPeak® NMNH (Reduced NMN) is pioneering next-phase research, including long-term biological age tracking and expanded health markers like cognitive performance, sleep quality, cardiovascular health, brian fuction, etc. Brands are invited to collaborate on NMNH supplements innovations that redefine aging.
Follow UthPeak® for updates on peer-reviewed publications and upcoming trials. Partner with us to bring science-backed longevity to your customers.
Comments